Microvascular Therapeutics Inc.
Tucson, AZ
- UEI
- ZA54X6LR5AS3
- CAGE
- 7LE82
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1635 E 18th St, Tucson, AZ 85719, USA
- Website
- mvtpharma.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| IND enabling studies for targeted phase shift microbubbles for sonothrombolysis | Defense Health Agency | $3,984,239 | |
| Selectivity and efficacy of CD90-targeted phase shift microbubbles for hifu-mediated non-thermal ablation of brain… | National Cancer Institute | $795,194 | |
| Ultrasound-mediated thrombolysis for MVO and PAO treatment. - abstract encouraging results have been obtained with… | National Heart Lung and Blood Institute | $3,000,486 | |
| Targeted ultrasound contrast agents for the disruption of alzheimer's plaques. | National Institute on Aging | $364,170 | |
| Ultrasound-stimulated phase-change contrast agents for sonothrombolysis. | National Heart Lung and Blood Institute | $378,190 |
About Microvascular Therapeutics Inc.
Microvascular Therapeutics Inc. is a for-profit biotechnology company focused on developing targeted ultrasound contrast agents and delivery systems for diagnostic and therapeutic applications. As per SAM.gov records, the company has been a registered federal government vendor since 2016. Through various prime and subaward grants from agencies including the NIH, DoD, and NSF, Microvascular Therapeutics provides research and development services aimed at advancing ultrasound and microbubble technologies for biomedical applications.
Specifically, Microvascular Therapeutics has been awarded federal grants to conduct preclinical research on microbubbles and nanodroplets for enhanced ultrasound imaging and treatment of cardiovascular diseases, cancer, and neurological disorders. Project activities include formulation of ligand-targeted and acoustically-active nanoparticles, evaluation of binding selectivity and drug delivery capabilities, and testing of thrombus disruption and non-thermal tumor ablation efficacy in animal models. Major grant programs supporting this work include the NIH SBIR and STTR programs, the DoD Military Medical Research and Development program, and the NSF Engineering Research Centers program. Partners on funded projects have included university research groups and medical device manufacturers seeking to translate the technologies for clinical use. Through this body of federally-funded research, Microvascular Therapeutics provides specialized contrast agent platforms, analytical testing services, and translational expertise to advance ultrasonic theranostics.
Quick answers
What is Microvascular Therapeutics Inc.'s UEI?
Microvascular Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is ZA54X6LR5AS3.
What is Microvascular Therapeutics Inc.'s CAGE code?
Microvascular Therapeutics Inc.'s CAGE code is 7LE82.
What is Microvascular Therapeutics Inc.'s primary NAICS code?
Microvascular Therapeutics Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Microvascular Therapeutics Inc. located?
Microvascular Therapeutics Inc.'s physical address in SAM.gov is 1635 E 18th St, Tucson, AZ 85719, USA.
Is Microvascular Therapeutics Inc. registered in SAM.gov?
Yes. Microvascular Therapeutics Inc.'s SAM.gov registration is active through January 29, 2027.
What is Microvascular Therapeutics Inc.'s most recent federal award?
Microvascular Therapeutics Inc.'s most recent federal grant award is IND enabling studies for targeted phase shift microbubbles for sonothrombolysis (HT94252310893), from Defense Health Agency, on September 1, 2023.
On GovTribe
See Microvascular Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors